Dutch chemicals group DSM said on Thursday it aims to boost core profit to between €1.4bn and €1.6bn by 2013, by targeting emerging markets exposure and acquisitions.

Sales growth should be an annual 5% to 7%, the company said.
‘We have set ambitious sales and profitability targets. To realise these, we will take all four growth drivers, which are high growth economies, innovation, sustainability and acquisitions and partnerships, to the next level, CEO Feike Sijbesma said in a statement.
Over the past 10 years, DSM has been revamping its operations, selling its bulk chemicals activities and moving into life sciences, nutrition and enzyme technology in a bid to make itself more resistant to economic swings.